InsiderSignal.AI

InsiderSignal.ai

PAHC - Phibro Animal Health Corp

Insider Sale by Bendheim Jack (Pres, CEO, 10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Bendheim Jack, serving as Pres, CEO, 10% owner at Phibro Animal Health Corp (PAHC), sold 21,120 shares at $52.27 per share, for a total transaction value of $1,103,938.00. Following this transaction, Bendheim Jack now holds 18,320 shares of PAHC.

This sale represents a 54.00% decrease in Bendheim Jack's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 24, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 2 days after the trade was made.

Phibro Animal Health Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Bendheim Jack

Pres, CEO, 10%

Jack C. Bendheim (age 78) is the Chairman, President, and Chief Executive Officer of Phibro Animal Health Corporation (PAHC), a role he has held in various capacities since joining the company in 1969.[[1]](https://fintool.com/app/research/companies/PAHC/people/jack-bendheim)[[2]](https://investors.pahc.com/governance/board-of-directors/person-details/default.aspx?ItemId=ebbc948f-8aa5-4994-bff5-9c004aaab4d0) His career at PAHC includes serving as Vice President & Treasurer (1975–1983), Executive Vice President & Treasurer (1983–1988), Chief Operating Officer (1988–1998), and CEO from 1998–2002 and again since March 2014, while acting as a director since 1984 and President since 1988.[[1]](https://fintool.com/app/research/companies/PAHC/people/jack-bendheim)[[2]](https://investors.pahc.com/governance/board-of-directors/person-details/default.aspx?ItemId=ebbc948f-8aa5-4994-bff5-9c004aaab4d0) Bendheim controls significant voting power (approx. 90.9%) through BFI Co., LLC, which he manages, making PAHC a controlled company under Nasdaq rules; he is the largest individual shareholder with over 53% ownership.[[1]](https://fintool.com/app/research/companies/PAHC/people/jack-bendheim)[[3]](https://matrixbcg.com/blogs/owners/pahc) Bendheim has held external roles such as President of HealthforAnimals (since March 2025), past Chairman of the Animal Health Institute, and former Director of Empire Resources, Inc.[[1]](https://fintool.com/app/research/companies/PAHC/people/jack-bendheim) A planned leadership transition announced in December 2025 will see him resign as CEO and President effective July 1, 2026, transitioning to Executive Chairman while his son, Daniel (Dani) Bendheim, assumes those roles.[[5]](https://www.stocktitan.net/sec-filings/PAHC/8-k-phibro-animal-health-corp-reports-material-event-dfa0eaaf26b3.html)

View full insider profile →

Trade Price

$52.27

Quantity

21,120

Total Value

$1,103,938.00

Shares Owned

18,320

Trade Date

Tuesday, February 24, 2026

3 days ago

SEC Filing Date

Thursday, February 26, 2026

Filed 2 days after trade

HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

About Phibro Animal Health Corp

Company Overview

No company information available
View news mentioning PAHC

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4327851

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime